Weight Loss Drug Wegovy Also Cuts Heart Risks

In a large clinical trial, the weight loss drug Wegovy was recently shown to reduce the overall risk of heart attacks, strokes, and cardiovascular deaths by 20% in the study population.

The double-blind placebo-controlled trial included over 17,000 adults over the age of 45 years who were overweight or had obesity. All participants had been diagnosed with cardiovascular disease, but none had a prior history of diabetes. Participants were given Wegovy or a placebo once weekly for up to five years. During that time, the incidence of major adverse…